Lafayette Hill, PA, United States of America

Eric Steven Manas

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 160(Granted Patents)

Location History:

Lafayette Hill, PA (US) (2004 - 2014)
Collegeville, PA (US) (2018 - 2024)

Company Filing History:

Glaxosmithkline Intellectual Property Development Limited

Years Active: 2004-2024

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11999746 - Compounds (2024-06-04),

2. 10428078 - Compounds (2019-10-01),

3. 10125141 - Compounds (2018-11-13),

4. 8871928 - Tricyclic compounds, preparation methods, and their uses (2014-10-28),

5. 7555415 - Methods for the design of estrogen receptor ligands (2009-06-30),

6. 7531564 - Substituted benzoxazoles as estrogenic agents (2009-05-12),

7. 7488832 - Azolylacylguanidines as β-secretase inhibitors (2009-02-10),

8. 7250440 - (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents (2007-07-31),

9. 7148247 - Substituted benzoxazoles as estrogenic agents (2006-12-12),

10. 7129258 - Substituted benzoxazoles as estrogenic agents (2006-10-31),

11. 7067524 - Substituted phenyl naphthalenes as estrogenic agents (2006-06-27),

12. 6914074 - Substituted phenyl naphthalenes as estrogenic agents (2005-07-05),

13. 6794403 - Substituted benzoxazoles as estrogenic agents (2004-09-21),

Title: The Innovative Contributions of Eric Steven Manas

Introduction

Eric Steven Manas is a notable inventor based in Lafayette Hill, PA, with a remarkable portfolio of 13 patents. His work primarily focuses on the development of novel compounds that have significant implications in the medical field, particularly in the treatment of diseases such as Alzheimer's.

Latest Patents

Among his latest patents, Eric has developed compounds that inhibit Lp-PLA activity. These inventions include processes for their preparation, compositions containing these compounds, and their applications in treating diseases associated with Lp-PLA activity, such as Alzheimer's disease. His innovative approach to these compounds showcases his commitment to advancing medical science.

Career Highlights

Eric has had a distinguished career, having worked with prominent companies such as Wyeth and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.

Collaborations

Throughout his career, Eric has collaborated with notable professionals, including Michael Sotirios Malamas and Robert E McDevitt. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Eric Steven Manas stands out as a significant figure in the realm of innovation, particularly in the development of compounds for medical applications. His contributions continue to influence the field and offer hope for advancements in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.